Owing to problems in making high affinity human mAbs, there is interest in the therapeutic application of chimeric antibodies in which either the V domains orjust the hypervariable regions of rodent mAbs have been used to replace the equivalent parts of a human antibody (1, 2, and references therein). Whereas xenogeneic antibodies are highly immunogenic in man (see reference 3 for references), little is known about the immunogenicity of chimeric antibodies . It is unclear to what extent a particular V domain is characteristic of the species from which it originates, and therefore, whether a response will be elicited by an antibody in which only the V region is foreign . If there is such an antiidiotypic response, to what extent is it enhanced by linkage to foreign C domains? Here, we describe experiments carried out in the mouse that address these questions .
Results and Discussion
The response was compared of mice injected with one of three antibodies . The most xenogeneic antibody (HuVNP-Hu-y2) is composed of a human -y2 C region linked to a V domain that has the framework residues of the human NEW myeloma protein (Fig . 1) . A chimeric derivative (in which only the V region frameworks are human) was created by substituting the human C-y2 by the C-y2b of C57BL/6 mice to yield HuVNP-Moy2bb . In MOVNP-Mo-y2bb (the syngeneic antibody), the entire V domain is of mouse origin, the foreign framework residues having been substituted by mouse sequences. All the antibodies contain a mouse A L chain, as well as V hypervariable region sequences derived from a mouse antibody specific for NP Groups of (C57BL/6 x BALB/c)Fi mice were immunized intraperitoneally with the three antibodies in CFA . The mice made a strong primary and secondary response to the most xenogeneic antibody, a reduced yet nevertheless considerable response to the chimeric antibody, but no detectable response to the syngeneic antibody (Fig. 2 A) . In the mice immunized with the HuVNP-Huy2, a large proportion of the response was directed against the human -y2 C region, as witnessed by binding inhibition assays using a human IgG2 myeloma protein; much less inhibition was given by an antibody (HuVNP-Hue) whose H chain is composed of the HuVNP V domain linked to human Cc (Fig. 3 A, I ). The anti -V region response elicited by the xenogeneic antibody HuVNP-Huy2 was measured using a HuVNP-Hue coat ; it was of a similar order to that elicited by HuVNP-Mo-y2bb (Fig . 3 B) . Thus, a considerable proportion of the response to the xenogeneic antibody was directed against the V region ; this antiidiotypic response was not diminished by using the chimeric antibody with self C regions .
The antiidiotypic response in the mice immunized with either HuVNP-Huy2 or HuVNP-Mo,y2bb was not exclusively directed against the human frameworks of the immunizing antibody, although these are the only foreign determinants in the V domain . The mice contained a significant titre ofantibodies that recognized MOVNP (Fig . 3, A and B) . A more direct demonstration that it is possible to elicit an antibody response to syngeneic V domains is provided by immunizing mice with MOVNP-Huy2 (Fig. 3 B) . Thus, the mouse can make a response to its own V domains, and probably to the hypervariable regions themselves . However, this response is not elicited unless the administered antibody contains some foreign determinants.
As a better system to mimic the use of mAbs directed against tumor cell surface markers, mice were challenged with syngeneic spleen cells to which antibody had been bound . While the responses were considerably weaker than to the antibodies administered in CFA, the cell-bound xenogeneic and chimeric antibodies nevertheless elicited a clear response with the major part of the response to HUVNP-Huy2 being directed against the C region (Figs . 3 A and 2 B) . Within the variation from individual animals, there was no clear difference in the immunogenicity of the xenogeneic and chimeric antibodies . The contrast between these results and those obtained using Freund's might be accounted for by the fact that mouse IgG2b, but not human IgG2, binds to some mouse Fc receptors (6) . Although administration of a syngeneic antibody need not elicit an antiantibody BRiJGGEMANN ET AL . BRIEF DEFINITIVE REPORT response, polymorphism within the human population may lead to responses even to wholly human antibodies. To compare the magnitude of such an allotyppc response with the response mounted against foreign V region frameworks, MOVNPMo,y2bb was injected into both C57BL/6 (the strain from which the antibody originates) and BALB/c mice . Unlike C57BL/6, the BALB/c mice made a strong response against MOVNP-Moy2bb, recognizing both V and C domains (Fig. 4 A) . Although immune response genes could well play a role (7), the difference in the response obtained with the C57BL/6, BALB/c, and Ft mice is likely to be due to the difference in Igh haplotypes . This was confirmed by comparing the responses of C57BL/Ks (H2 Igh') mice (Fig. 4 B) . Thus, an antibody with both foreign C domains and foreign V frameworks was strongly immunogenic, eliciting a response that was largely directed against the C region but with a substantial component against the V. In a chimeric derivative (in which only the V region frameworks are foreign), the anti-C response was abolished but the response to the V remained and was unattenuated . While all foreign framework sequences may not prove equally immunogenic, the results indicate that, short of administering an autologous antibody, therapeutic applications should make use of antibodies in which care has been taken to reduce the V region immunogenicity. However, the immunogenicity of antibodies in which the hypervariable regions are the sole foreign determinants is an unknown quantity and is an important focus for further research . Extrapolating to therapy in man, the results caution that, even with wholly human antibodies, problems may be encountered with allogeneic responses directed against both the V and the C. Ultimately, it may prove advisable not just to use humanized antibodies, but to use antibodies whose allotype is matched to that of the patient.
Summary
Mice were immunized with model xenogeneic (both the V frameworks and the C domains of human origin), chimeric (just VH frameworks human), or self antibodies, and the antiantibody responses were dissected. Only the self antibody did not elicit a response. A strong response was elicited by the most xenogeneic antibody with -90% against the C and -10%O against the V. The anti-V response was not
